TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. - Wikidata - awgldk - TriplyDB

TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression.

TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression.

http://www.wikidata.org/entity/Q36001319

about

MCF10CA1a.cl1 MCF10CA1h MCF10A1 MCF10AT1k.cl2

P1343

Expression of GATA3 in MDA-MB-231 triple-negative breast cancer cells induces a growth inhibitory response to TGFß The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta.Transforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition Programmed cell death protein-1/programmed cell death ligand-1 pathway inhibition and predictive biomarkers: understanding transforming growth factor-beta role Transient tumor-fibroblast interactions increase tumor cell malignancy by a TGF-Beta mediated mechanism in a mouse xenograft model of breast cancer Real-time motion analysis reveals cell directionality as an indicator of breast cancer progression A cytokine-neutralizing antibody as a structural mimetic of 2 receptor interactions Role of TGFβ in regulation of the tumor microenvironment and drug delivery (review)TGFβ Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis Doxorubicin in combination with a small TGFbeta inhibitor: a potential novel therapy for metastatic breast cancer in mouse models Proteome-wide profiling of the MCF10AT breast cancer progression model Twenty-five years of PTHrP progress: from cancer hormone to multifunctional cytokine.Supervillin reorganizes the actin cytoskeleton and increases invadopodial efficiency.Smad4-expression is decreased in breast cancer tissues: a retrospective study.Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines.p130Cas is required for mammary tumor growth and transforming growth factor-beta-mediated metastasis through regulation of Smad2/3 activity.Two faces of TGF-beta1 in breast cancer.TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFβ-mediated breast cancer cell migration and invasion.A microRNA expression signature for cervical cancer prognosis.Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling.Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis.Rapamycin enhances the antiproliferative effect of transforming growth factor-β on MCF-7 human breast cancer cells An integrated genomic approach identifies persistent tumor suppressive effects of transforming growth factor-β in human breast cancer Cathepsin B is the driving force of esophageal cell invasion in a fibroblast-dependent manner.Targeting the Transforming Growth Factor-beta pathway inhibits human basal-like breast cancer metastasis.TGFbeta signaling supports survival and metastasis of endometrial cancer cells.The microRNA-23b/27b/24 cluster promotes breast cancer lung metastasis by targeting metastasis-suppressive gene prosaposin.SMAD4 is a potential prognostic marker in human breast carcinomas.Genetic suppression of inflammation blocks the tumor-promoting effects of TGF-β in gastric tissue.Perspectives on tissue interactions in development and disease.Tgf-beta signaling pathway in lung adenocarcinoma invasion.Disabled-2 downregulation promotes epithelial-to-mesenchymal transition LEF-1 and TCF4 expression correlate inversely with survival in colorectal cancer Serum starvation regulates E-cadherin upregulation via activation of c-Src in non-small-cell lung cancer A549 cells.Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-beta signaling in ErbB2/Neu-induced tumors from transgenic mice.A potential anti-tumor herbal medicine, Corilagin, inhibits ovarian cancer cell growth through blocking the TGF-β signaling pathways.Adaptive and maladptive effects of SMAD3 signaling in the adult heart after hemodynamic pressure overloading Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells.

P2860

Q54904438-E8AE55CD-A917-463C-A4D7-305A35AD7E54 Q54904446-729F9724-A79C-496F-BD0C-5C17BA82A666 Q95986692-8F8052AA-B220-4991-8163-414C872FDDDD Q95986693-A78E9854-D77A-4656-AA23-271B127AFB27

P1343

Q21133567-D6F64D89-0D7C-4412-B2F4-B1227CD3950A Q21195231-FB1DBA0D-5FFB-416E-A115-963A12D2D7A4 Q24316645-61C32767-EAAF-49B4-85CB-F01FDB67FE1B Q26769734-590B1634-8D87-4947-A529-9880C18D7F7B Q27332206-C640960C-3F6B-4BBA-BEA7-53A48C8A4A56 Q27334635-E0BABF39-F343-477F-9E75-DC8EB5C7CA05 Q27653116-82DEA1E0-C452-4C01-8841-2EA9665FD281 Q28081170-3BFC3D49-518F-421E-8EA9-E9132FCB353A Q28083107-0C7B592F-4829-4C10-930A-D2F43183E499 Q28473783-64EFEDB7-A3C9-48A0-92EF-247BDC6C826C Q28474333-900CBA88-7EE6-4E26-BEEA-857174124018 Q30416231-8BEBE184-A5E9-49B7-A31A-1E192A433459 Q30485711-4240C993-4E48-46DA-80C1-86315177D474 Q33232550-C12768D0-8981-4D25-B788-17833E9E8AD3 Q33532630-9F2D5A99-1131-46A3-8298-C0BFF907B6C6 Q33553472-EE785E08-9B0E-44DD-A3AC-EAA20D97562F Q33661529-FD1D24B2-E071-4EFB-95D0-30830E6A1D2D Q33734595-2A7E4C11-3FB7-4E6F-990B-9AB445C9C228 Q33739245-DDCB6067-26E0-49C7-BE6E-E63E57665DA6 Q33748347-A275A3C4-8317-4710-B21A-93FBA8DE8EB8 Q33839230-74797DBD-C1E2-4102-A618-3D7C5FBB9BEB Q33840435-AA7D04A6-A8CC-4346-B67E-EF1FD71859B1 Q33847432-1E55D5AF-21C7-4B24-917C-E17CC04A8314 Q33892460-CA4020EF-C996-48F2-BC3E-28970E791B6E Q33918879-64185859-100C-407B-9253-07B168FA073A Q33933880-4BBFD049-D8B6-4133-BC9A-FA77DF799DC4 Q33980127-499E4AF2-FC66-4938-843F-622D0FDB0ABE Q34070330-E7237E01-6D2F-431E-85CF-21E29F233812 Q34079958-312E82B8-0DA4-4930-B292-DDC955BBB0E1 Q34154062-CDB45676-0780-4305-A8E1-99E67048F988 Q34330027-BC234D43-7140-4A76-94FE-23ACFEC6B32D Q34356297-3964C095-68C2-4891-9DAC-3A3EC11F1FBF Q34363558-776D15E1-9DA6-4203-AE2F-1C89B7283248 Q34375332-DFA9B84B-8267-4629-89A0-1EB4C14A5646 Q34439502-03CBDEB2-B338-42F1-A6BC-CF9A888185C2 Q34521619-49D51347-6119-4528-8DA5-9482D1DA00E7 Q34587399-A69E98F0-B394-4508-8743-71650938ADD2 Q34722251-8B09014B-F8C0-4EE8-B5B4-BE6CB47DF55A Q34781947-855322EB-76AA-49DA-A218-002458AAE3D1 Q34887552-BED4DC19-56A9-4955-9E34-0EF1E351FAA6

P2860

TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression.

http://www.wikidata.org/entity/Q36001319

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

TGF-beta switches from tumor s ...... of breast cancer progression.

@ast

TGF-beta switches from tumor s ...... of breast cancer progression.

@en

type

label

TGF-beta switches from tumor s ...... of breast cancer progression.

@ast

TGF-beta switches from tumor s ...... of breast cancer progression.

@en

prefLabel

TGF-beta switches from tumor s ...... of breast cancer progression.

@ast

TGF-beta switches from tumor s ...... of breast cancer progression.

@en

P1433

Q36001319-36A293E1-8E5E-4DCA-93B4-EAB183533789

P1476

Q36001319-38ECE6FD-5098-41FE-9029-E4EA7F4C0B2B

P2093

Q36001319-0E3DE26A-156A-44B0-85DD-B8CD22A37948

Q36001319-2244D583-FA93-42E9-88CF-F02CC9F089DA

Q36001319-2A12C7F9-291E-466E-8C24-5E03C3DD0BEA

Q36001319-5CC5D2C1-DB4A-4AA2-8DAC-9A5A50680101

Q36001319-77F00642-7D03-4E75-BC05-7BF3EC8F7BD8

Q36001319-996755C5-389B-47EE-8A7E-856AF6034F28

P2860

Q36001319-1265D647-AB33-48AC-A319-683808141D46

Q36001319-17B2AEEF-455C-4CAA-81E6-24BD2557477F

Q36001319-364786C8-A5E3-4DDE-BD87-FF22C56FB390

Q36001319-36F2A5E6-6A89-47C3-8B72-E5BB4D9E2678

Q36001319-49118F7E-BC1C-4338-B011-D1F810B428A4

Q36001319-4CD66F20-5823-469D-A430-31C8B06FFB72

Q36001319-4D554A13-2BC1-4316-A4AF-331B240390E9

Q36001319-5483D9A6-BA7B-4076-840A-09DCFD49EE70

Q36001319-71A7B5FC-BB65-4E93-BCC7-B86320BF85EE

Q36001319-75BAED49-CA33-4D7B-9020-154C48BAED2C

P304

Q36001319-FF82F996-1076-4A61-AFDE-3B601C40C92E

P31

Q36001319-D94B2AAB-A44C-43F5-B0B1-F8428979B5B3

P356

Q36001319-2626195B-4428-4615-B98F-6FB0F1F4E61E

P407

Q36001319-0890ABBB-92C2-46D0-87C7-6BD7C4ED4655

P433

Q36001319-9D89ECEB-FC67-4FDC-AE43-6706F2D2B177

P478

Q36001319-32C506B0-BC0E-472C-B2AB-1E810E67CBAC

P50

Q36001319-BD2E927B-2A31-438E-A151-00C8C611B4FB

P577

Q36001319-F4C0577A-C2E7-4822-BB44-378A42669737

P698

Q36001319-661C8B37-A140-4BFC-B3E4-0D221B01F452

P932

Q36001319-5D1B4AB5-7252-4E63-B02B-69C7881A9E59

P356

P1433

Journal of Clinical Investigation

P1476

TGF-beta switches from tumor s ...... l of breast cancer progression

@en

P2093

Binwu Tang

http://www.w3.org/2001/XMLSchema#string

Fred R Miller

http://www.w3.org/2001/XMLSchema#string

Mary Vu

http://www.w3.org/2001/XMLSchema#string

Miriam R Anver

http://www.w3.org/2001/XMLSchema#string

Steven J Santner

http://www.w3.org/2001/XMLSchema#string

Timberly Booker

http://www.w3.org/2001/XMLSchema#string

P2860

Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells.

TGFbeta signaling in growth control, cancer, and heritable disorders

Putting tumours in context

Production of high-titer helper-free retroviruses by transient transfection

TGF-beta signaling in tumor suppression and cancer progression

Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10

The microenvironment of the tumour-host interface

Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer.

TGF-beta signaling: positive and negative effects on tumorigenesis.

MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor beta type II receptor expression in human breast cancer cells.

P304

1116-1124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI200318899

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P50

Lalage M Wakefield

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14523048

http://www.w3.org/2001/XMLSchema#string

P932

198530

http://www.w3.org/2001/XMLSchema#string